Q3 2025 saw lower sales but improved operating results due to cost reductions. Strategic focus is on leveraging EU policy shifts and expanding in Spain and North America, with ongoing R&D and international partnerships. Risks remain around contract payments and funding.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.